Research@StAndrews
 
The University of St Andrews

Research@StAndrews:FullText >
University of St Andrews Research >
University of St Andrews Research >
University of St Andrews Research >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10023/1908
This item has been viewed 4 times in the last year. View Statistics

Files in This Item:

File Description SizeFormat
PLoSone2009vol4_5Identification.pdf485.75 kBAdobe PDFView/Open
Title: Identification of 2-aminothiazole-4-carboxylate derivatives active against Mycobacterium tuberculosis H37Rv and the beta-ketoacyl-ACP synthase mtFabH
Authors: Al-Balas, Qosay
Anthony, Nahoum G.
Al-Jaidi, Bilal
Alnimr, Amani
Abbott, Grainne
Brown, Alistair K.
Taylor, Rebecca C.
Besra, Gurdyal S.
McHugh, Timothy D.
Gillespie, Stephen H.
Johnston, Blair F.
Mackay, Simon P.
Coxon, Geoffrey D.
Keywords: QD Chemistry
Issue Date: 19-May-2009
Citation: Al-Balas , Q , Anthony , N G , Al-Jaidi , B , Alnimr , A , Abbott , G , Brown , A K , Taylor , R C , Besra , G S , McHugh , T D , Gillespie , S H , Johnston , B F , Mackay , S P & Coxon , G D 2009 , ' Identification of 2-aminothiazole-4-carboxylate derivatives active against Mycobacterium tuberculosis H37Rv and the beta-ketoacyl-ACP synthase mtFabH ' PLoS One , vol 4 , no. 5 , pp. e5617 .
Abstract: Background: Tuberculosis (TB) is a disease which kills two million people every year and infects approximately over one-third of the world's population. The difficulty in managing tuberculosis is the prolonged treatment duration, the emergence of drug resistance and co-infection with HIV/AIDS. Tuberculosis control requires new drugs that act at novel drug targets to help combat resistant forms of Mycobacterium tuberculosis and reduce treatment duration. Methodology/Principal Findings: Our approach was to modify the naturally occurring and synthetically challenging antibiotic thiolactomycin (TLM) to the more tractable 2-aminothiazole-4-carboxylate scaffold to generate compounds that mimic TLM's novel mode of action. We report here the identification of a series of compounds possessing excellent activity against M. tuberculosis H37Rv and, dissociatively, against the beta-ketoacyl synthase enzyme mtFabH which is targeted by TLM. Specifically, methyl 2-amino-5-benzylthiazole-4-carboxylate was found to inhibit M. tuberculosis H37Rv with an MIC of 0.06 mu g/ml (240 nM), but showed no activity against mtFabH, whereas methyl 2-(2-bromoacetamido)-5-(3-chlorophenyl)thiazole-4-carboxylate inhibited mtFabH with an IC50 of 0.95 +/- 0.05 mu g/ml (2.43 +/- 0.13 mu M) but was not active against the whole cell organism. Conclusions/Significance: These findings clearly identify the 2-aminothiazole-4-carboxylate scaffold as a promising new template towards the discovery of a new class of anti-tubercular agents.
Version: Publisher PDF
Status: Peer reviewed
URI: http://hdl.handle.net/10023/1908
DOI: http://dx.doi.org/10.1371/journal.pone.0005617
ISSN: 1932-6203
Type: Journal article
Rights: © 2009 Al-Balas et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Appears in Collections:University of St Andrews Research
Medicine Research
Biomedical Sciences Research Complex (BSRC) Research



This item is protected by original copyright

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

DSpace Software Copyright © 2002-2012  Duraspace - Feedback
For help contact: Digital-Repository@st-andrews.ac.uk | Copyright for this page belongs to St Andrews University Library | Terms and Conditions (Cookies)